Combining incretin agonists produces additive nausea, delayed gastric emptying, and constipation
The medications used, such as Semaglutide , Tirzepatide , and Zepbound , are all FDA-approved and backed by clinical research for both safety and effectiveness
Active Ingredient: Tirzepatide Tirzepatide is a dual agonist it activates GLP-1 receptors and GIP (glucose-dependent insulinotropic polypeptide) receptors
It serves a specific physiological purpose in this combination, and understanding that purpose helps you make better decisions about your protocol
Type 2 Diabetes The robust glycemic improvements make retatrutide a strong option for people with type 2 diabetes, especially those who also need significant weight loss
Inflammation and Hormonal Changes Type 2 diabetes often overlaps with having excess body fat, elevated stress hormones and low-grade inflammation, which can contribute to feeling run down